- Home
- PRVA vs LIVN Comparison
PRVA vs LIVN Comparison
Compare PRVA & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRVA
- LIVN
- Stock Information
- Founded
- PRVA 2007
- LIVN 1987
- Country
- PRVA United States
- LIVN United Kingdom
- Employees
- PRVA N/A
- LIVN N/A
- Industry
- PRVA Retail: Computer Software & Peripheral Equipment
- LIVN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- PRVA Technology
- LIVN Health Care
- Exchange
- PRVA Nasdaq
- LIVN Nasdaq
- Market Cap
- PRVA 2.8B
- LIVN 2.6B
- IPO Year
- PRVA 2021
- LIVN 1993
- Fundamental
- Price
- PRVA $24.52
- LIVN $47.44
- Analyst Decision
- PRVA Strong Buy
- LIVN Buy
- Analyst Count
- PRVA 17
- LIVN 7
- Target Price
- PRVA $24.71
- LIVN $67.14
- AVG Volume (30 Days)
- PRVA 611.2K
- LIVN 447.1K
- Earning Date
- PRVA 02-27-2025
- LIVN 02-25-2025
- Dividend Yield
- PRVA N/A
- LIVN N/A
- EPS Growth
- PRVA N/A
- LIVN 759.09
- EPS
- PRVA 0.11
- LIVN 0.43
- Revenue
- PRVA $1,716,318,000.00
- LIVN $1,241,739,000.00
- Revenue This Year
- PRVA $78.50
- LIVN $10.18
- Revenue Next Year
- PRVA $11.52
- LIVN $5.43
- P/E Ratio
- PRVA $227.34
- LIVN $110.76
- Revenue Growth
- PRVA 8.54
- LIVN 11.04
- 52 Week Low
- PRVA $15.92
- LIVN $43.15
- 52 Week High
- PRVA $25.67
- LIVN $64.48
- Technical
- Relative Strength Index (RSI)
- PRVA 61.94
- LIVN 44.11
- Support Level
- PRVA $23.49
- LIVN $46.75
- Resistance Level
- PRVA $25.67
- LIVN $49.96
- Average True Range (ATR)
- PRVA 0.75
- LIVN 1.24
- MACD
- PRVA 0.06
- LIVN -0.09
- Stochastic Oscillator
- PRVA 64.72
- LIVN 21.50
About PRVA Privia Health Group Inc.
Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.
About LIVN LivaNova PLC
UK-based LivaNova was born of a combination between Cyberonics in the us and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management and heart valve businesses. It derives roughly half of its revenue from the us market, another 21% from Europe, and the remainder from the rest of the world.